Skip to content

GCRI · Technology

پلاتفۆرمەکانی بایۆتەکنەلۆجی

Biotechnology platforms apply biological systems to produce medicines, diagnostics, materials and agricultural products. They expand response capacity for health threats while introducing dual-use and biosafety concerns. Biotechnology and Biosecurity stewards this page for the Nexus Consortium.

02ڕێبازەکە

What biotechnology platforms covers.

  1. 01

    Core methods

    genetic engineering; bioprocess design; high-throughput screening; diagnostic assay development; vaccine platform development; biosafety risk assessment.

  2. 02

    Data and instruments

    laboratory automation systems; bioreactor process data; clinical trial registries; genomic databases; manufacturing quality records.

  3. 03

    پشتڕاستکردنەوە

    Products are evaluated through staged preclinical and clinical testing and manufacturing quality controls. Regulatory review and independent replication check claims.

  4. 04

    سنوورەکان

    Scale-up from laboratory to production often fails or takes time. Containment and oversight can lag behind technical capability.

  5. 05

    Use in risk decisions

    Biotechnology capacity shapes how quickly countermeasures can be produced in a crisis. Its supply chains and dual-use potential are part of biosecurity planning.

03Reference practice

Biotechnology is governed by biosafety, biosecurity and responsible-use frameworks.

ئاماژەئەوەی دایدەنێت
WHO Laboratory Biosafety ManualRisk-based biosafety
WHO responsible life sciences frameworkDual-use governance
Cartagena ProtocolLiving modified organisms
Biological Weapons ConventionProhibition and confidence-building measures

This page covers capacity and oversight only.

04پرۆسە

چۆن پرۆسەکە کار دەکات.

Process explorer · Process

Biotechnology platforms: Life-science research oversight

7 steps3 stages2 gates

پرۆسە

Biotechnology platforms: Life-science research oversight

Capacity and oversight only, following the WHO Laboratory biosafety manual (4th edition) and WHO life sciences framework, with no methods, agents or protocols.

  1. 01 Institution

    1. 01ProposalDatasetA research institution submits a proposal for review. The place is set by the page.
    2. 02Institutional committeeGate · The institutionA biosafety committee is an independent institutional review group, reporting to senior management. Review follows national rules.
    3. 03Conditions: risk control measuresStepA risk assessment sets the measures: core requirements, heightened control measures or maximum containment, not one biosafety level.
    4. 04Training and competenceStepActual risk depends on the agent, the procedure and staff competency. Training and personnel competence have their own section.
  2. 02 Assurance

    1. 05Audit and inspectionGateMany labs run cooperative inspections: periodic self-audits plus a rarer, deeper evaluation with the biosafety officer or committee.
    2. 06Emergency and incident responseStepThe manual covers emergency and incident response at each level of measures. External reporting of incidents depends on national rules.
  3. 03 National

    1. 07National oversightDecision · Independent reviewerThe WHO framework is for those who govern biorisks, such as policy makers and regulators. National bodies set national rules.

Neutral outline of a published external standard or method, from its issuing body. Not a record of operation. Nexus does not perform, certify or approve any step shown. A gate or decision belongs to the party the source names. The Biological Weapons Convention is not drawn in this flow. The framework is the WHO global guidance framework for the responsible use of the life sciences.

05In systemic risk work

Platform capacity is preparedness.

Biotechnology platforms (diagnostics, vaccine and therapeutic manufacturing) determine how quickly countries can respond to outbreaks and crop diseases. Systemic analysis looks at geographic concentration of capacity and at oversight arrangements, not at laboratory methods.

  • Map manufacturing concentration for countermeasures.
  • Assess regulatory reliance arrangements that speed approvals.
  • Review oversight capacity alongside research capacity.
  • Oversight work sits on Biotechnology and Biosecurity.
07پارێزەرایەتی

Who maintains this page.

Biotechnology and Biosecurity stewards biotechnology platforms: it keeps this description current and reviews how the method is applied across the platforms.

08سەرچاوەکان

Where this page’s references lead.

ئەو لەش و بەڵگەنامانەی ئەم لاپەڕەیەیان لەگەڵ دەخوێنرێتەوە. دۆخ و وەشانەکان دەگۆڕێن؛ هەر بەستەرێک دەچێتە لای لەشی دەرکەر.

09پرسیارەکان

پرسیار و وەڵام.

Why does one institution host every method page?
GCRI hosts the STEM Commons so that each method has one canonical description. Platforms link to it rather than repeat it, which keeps definitions consistent.
How do I suggest a correction to a method page?
Write to the integrity concern form with the passage and the reason.
ڕاپۆرتەکانبەشداربە

لەم لاپەڕەیەوە بەڵگە پێشکەش بکە.

Reports بڵاوکراوەی وەرزیی کۆنسۆرتیۆم ـە. ئەوەی تۆ لەسەر ئەم بابەتە دەیزانیت دەتوانێت لە وەشانی داهاتوودا ببێتە بەڵگە، کەیس یان ڕاستکردنەوە، بە ناوی خۆتەوە و لەژێر CC BY 4.0 بڵاو دەکرێتەوە کاتێک کاری خۆتە.

GCRI
Global Centre for Risk and Innovation

ڕێگایەک، کۆمەڵە داتایەک یان پرسیارێک بهێنە.

زانیاری و پرسیار ئەمڕۆ کراوەن. پرسیارێک ژمارەی ئاماژەی پێدەدرێت و هەنگاوی دواتر دیاری دەکات؛ داواکاری، پارەدان، تەرخانکردنی کۆمپیوتەر و تۆمارکردن تەنیا کاتێک دەکرێنەوە کە تیم، مەرج و توانای پێداچوونەوەیان هەبێت.